The Supreme Court’s , ruling striking down President Trump’s country-specific “reciprocal” tariffs offers some relief to consumers facing higher import costs, but the economic landscape remains complex. While the decision invalidates tariffs imposed under the International Emergency Economic Powers Act of 1977 (IEEPA), significant tariffs remain in place, impacting several key industries.
The automotive industry continues to grapple with billions of dollars in tariff costs, dependent on the origin of imported parts and vehicles. The Trump administration previously implemented a 25% tariff on vehicles and certain auto parts, citing national security concerns. While some deals were struck to lower these levies to between 10% and 15% with countries like the United Kingdom and Japan, the full impact of these changes remains unclear.
Lenny LaRocca, U.S. Automotive lead for consulting firm KPMG, emphasized the ongoing uncertainty. “With today’s decision out and subsequent developments, there remain many unknowns and important questions still to be answered. Here’s not a moment to ease up,” he stated. “Automakers should continue planning for multiple scenarios and keep supply chain considerations top of mind as the trade and tariff landscape continues to evolve.”
Major automakers, like General Motors, anticipate substantial tariff costs. General Motors expects between $3 billion and $4 billion in tariff costs this year, while Ford Motor anticipates a roughly flat net tariff impact of $2 billion in . Ford stated it is continuing to work with the government on policies that “promote a strong and globally competitive U.S. Auto sector.”
The pharmaceutical industry faces considerable uncertainty. President Trump has repeatedly threatened tariffs on pharmaceutical imports, though these have not yet been enacted, partly due to negotiated multiyear deals with drugmakers. However, these tariffs could still be implemented under Section 232 of the Trade Expansion Act of 1962.
The administration has previously floated the possibility of tariffs reaching as high as 250% on pharmaceutical imports. Last , Trump threatened 200% tariffs, and a Section 232 investigation into the impact of pharmaceutical imports on national security is already underway.
These threats are intended to incentivize drug companies to manufacture more products within the United States. In , several companies, including Merck, Bristol Myers Squibb, Novartis, and others, reached a deal with Trump to voluntarily lower prices in exchange for a three-year exemption from pharmaceutical tariffs, contingent on further investment in U.S. Manufacturing.
The furniture industry received limited relief from the Supreme Court’s ruling. Last , items such as couches, kitchen cabinets, and vanities were subjected to higher tariffs under Section 232, and these duties will remain in effect. The roughly 25% tariffs are expected to rise to 50% in , adding to existing pressures from higher interest rates and inflation.
Smaller companies are disproportionately affected due to limited resources, while larger companies have faced financial difficulties, such as the bankruptcy of Value City Furniture’s parent company, American Signature Furniture, late last year.
Tariffs on steel and aluminum imports, enacted under Section 232, remain in place, impacting companies that rely on these materials for packaging and manufacturing. This affects major beverage companies like Coca-Cola, PepsiCo, Keurig Dr Pepper, and Reynolds.
Trump increased aluminum tariffs to 50% last year. However, some tariffs on key food products were rolled back prior to the Supreme Court’s ruling. In , Trump issued an executive order exempting several hundred agricultural products, including bananas, coffee, and spices, from tariffs. Similarly, in , he rescinded a 10% tariff on Brazilian pulp, a crucial component of paper towels, diapers, and toilet paper.
The Supreme Court’s decision regarding the IEEPA tariffs represents a partial victory for companies facing increased import costs. However, the continued application of Section 232 tariffs and the potential for new tariffs, as evidenced by Trump’s announcement of a new global 10% tariff following the ruling, underscore the ongoing volatility and complexity of the international trade landscape. The process of issuing refunds for tariffs already paid is expected to be complex and potentially lengthy, involving the U.S. Customs and Border Protection agency, the Court of International Trade, and other lower courts. Importers are likely to receive refunds eventually, but trade lawyers anticipate a “bumpy ride” during the process, with the substantial amount of money involved – estimated at $133 billion – presenting significant challenges for the courts.
